Guardian RT continuous glucose monitor that earned FDA approval in August 2005 for patients 18 years and older become available for kids with diabetes in the near future? Why would such technology be limited only to adults or, is that standard procedure for a new product for a period of time while performance statistics are compiled?
Answer:
Most new products are used first for adults and then later for kids. It is a great advance, but still has problems with missing many hypoglycemic episodes, as many as 20% in some studies. As we get more experience, we will know if this will be a great advance or just a small advance and we will also know about costs, accuracy, benefits, insurance reimbursements, hassles of use, etc.
SB
DTQ-20051001153050
Original posting 5 Oct 2005
Posted to Research: Monitoring